These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31635190)

  • 1. A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin.
    Kim D; Kim KM; Lim MH
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of mental retardation with paraphilia treated with depot leuprorelin.
    Park WS; Kim KM; Jung YW; Lim MH
    J Korean Med Sci; 2014 Sep; 29(9):1320-4. PubMed ID: 25246754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia.
    Choi JH; Lee JW; Lee JK; Jang S; Yoo M; Lee DB; Hong JW; Noh IS; Lim MH
    J Korean Med Sci; 2018 Sep; 33(37):e231. PubMed ID: 30190656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].
    Mayrhofer G; Wegner D; Voß T
    Aktuelle Urol; 2016 Dec; 47(6):487-490. PubMed ID: 27701680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists.
    Briken P; Nika E; Berner W
    J Sex Marital Ther; 2001; 27(1):45-55. PubMed ID: 11224953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases.
    Krueger RB; Kaplan MS
    Arch Sex Behav; 2001 Aug; 30(4):409-22. PubMed ID: 11446201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.
    Plosker GL; Brogden RN
    Drugs; 1994 Dec; 48(6):930-67. PubMed ID: 7533699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of endometriosis with leuprorelin acetate depot: a German multicentre study.
    Gerhard I; Schindler AE; Bühler K; Winkler U; Meinen K; Mancarella D; Hoffmann G; Schüssler B; Kimmig R; Kranzfelder D
    Clin Ther; 1992; 14 Suppl A():3-16. PubMed ID: 1535021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
    Reilly DR; Delva NJ; Hudson RW
    Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist.
    Dickey R
    Can J Psychiatry; 1992 Oct; 37(8):567-9. PubMed ID: 1423159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of pharmacokinetics and pharmacodynamics of leuprorelin acetate 3M-depot in patients with advanced and metastatic carcinoma of the prostate.
    Khan MS; O'Brien A
    Urol Int; 1998; 60(1):33-40. PubMed ID: 9519419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprorelin acetate granulomas: case reports and review of the literature.
    Yasukawa K; Sawamura D; Sugawara H; Kato N
    Br J Dermatol; 2005 May; 152(5):1045-7. PubMed ID: 15888168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations.
    Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Oya M
    J Med Econ; 2017 Nov; 20(11):1155-1162. PubMed ID: 28758810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia.
    Hoogeveen J; Van der Veer E
    J Sex Med; 2008 Mar; 5(3):626-30. PubMed ID: 17971105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.
    Chrisp P; Sorkin EM
    Drugs Aging; 1991; 1(6):487-509. PubMed ID: 1794035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of depot leuprorelin.
    Periti P; Mazzei T; Mini E
    Clin Pharmacokinet; 2002; 41(7):485-504. PubMed ID: 12083977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.